FACZEED Trademark

Trademark Overview

On Tuesday, March 23, 2021, a trademark application was filed for FACZEED with the United States Patent and Trademark Office. The USPTO has given the FACZEED trademark a serial number of 90596383. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 2, 2024. This trademark is owned by Bioverativ Therapeutics Inc.. The FACZEED trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of hemophilia; pharmaceutical products for the prevention and treatment of immunological diseases
faczeed

General Information

Serial Number90596383
Word MarkFACZEED
Filing DateTuesday, March 23, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 7, 2021

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of hemophilia; pharmaceutical products for the prevention and treatment of immunological diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, June 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioverativ Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameBioverativ Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Friday, March 26, 2021NEW APPLICATION ENTERED
Saturday, June 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 26, 2021ASSIGNED TO EXAMINER
Friday, October 29, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 7, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 10, 2022SOU TEAS EXTENSION RECEIVED
Friday, June 10, 2022SOU EXTENSION 1 FILED
Friday, June 10, 2022SOU EXTENSION 1 GRANTED
Tuesday, June 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 20, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 20, 2022SOU EXTENSION 2 FILED
Tuesday, December 20, 2022SOU EXTENSION 2 GRANTED
Thursday, December 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 6, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 6, 2023SOU EXTENSION 3 FILED
Tuesday, June 6, 2023SOU EXTENSION 3 GRANTED
Friday, June 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 19, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 19, 2023SOU EXTENSION 4 FILED
Tuesday, December 19, 2023SOU EXTENSION 4 GRANTED
Monday, September 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

faczeed pharmaceutical treatment prevention products diseases immunological blood disorders hemophilia